Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07034196 · ClinicalTrials.gov registry record · NA

Comparative Effectiveness of Primary Care Providers Trained in Rheumatoid Arthritis Management Versus Rheumatologist Care: A Randomized Controlled Trial

A NA study of Rheumatoid Arthritis (RA), sponsored by St. Lawrence Health System.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT07034196: Recruiting NA study of Rheumatoid Arthritis (RA), sponsored by St. Lawrence Health System.

NCT07034196 is a NA study of Rheumatoid Arthritis (RA) that is actively recruiting participants, run by St. Lawrence Health System. The registered enrollment target is 100 participants, below the 262-participant average among 17 other Rheumatoid Arthritis (RA) trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07034196, a NA study of Rheumatoid Arthritis (RA), is actively recruiting participants, sponsored by St. Lawrence Health System.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Rheumatoid arthritis (RA) is a complex autoimmune disease where the immune system attacks healthy joint tissue; causing pain, swelling, and stiffness of the joints. This disease effects lots of people in the US and can lead to major joint damage if not properly treated. In rural areas like northern NY, these are underserved areas for RA patients, thus many patients struggle to get the appropriate care. This model is testing whether primary care providers (PCP) can safely and effectively provide stable RA patients with the proper treatment rather than send them to a specialist. PCPs were trained through classes, case reviews, and a final exam. Patients will be randomly assigned to either see a trained PCP or their normal rheumatologist at the rheumatology clinic. This study will examine how patients are doing over a year using medical exams and patient feedback. If this model proves to be successful, it will make RA treatment easier and more affordable for patients.

Primary Outcome

The primary efficacy endpoint is the change in Disease Activity Score (DAS-28) response at 6 and 12 month intervals relative to baseline. It will be evaluated for non-inferiority of the treatment effect. The treatment difference between the Primary Care group and the Rheumatology group may be presented with point estimate and 95% CI.

Conditions Studied

Interventions

  • OTHER Primary Care Treatment in lieu of Rheumatologist

Study Locations (1)

New York

  • St. Lawrence Health - Potsdam

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-06-26
Est. Completion 2026-12-31
Phase NA
St. Lawrence Health System

2 total trials

What NCT07034196 shows while recruiting

NCT07034196 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 262-participant average among 17 other Rheumatoid Arthritis (RA) trials with a reported enrollment target (62% lower).

The record links to 1 condition, with Rheumatoid Arthritis (RA) appearing as the primary indexed condition, and to 1 intervention - of which Primary Care Treatment in lieu of Rheumatologist is the first listed.

NCT07034196 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT07034196 about?

NCT07034196 is a clinical study titled "Comparative Effectiveness of Primary Care Providers Trained in Rheumatoid Arthritis Management Versus Rheumatologist Care: A Randomized Controlled Trial". Rheumatoid arthritis (RA) is a complex autoimmune disease where the immune system attacks healthy joint tissue; causing pain, swelling, and stiffness of the joints. This disease effects lots of people in the US and can lead to major joint damage if not properly treated. In rural areas like northern ...

What is the current status of trial NCT07034196?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-06-26. Estimated completion is 2026-12-31.

What conditions does trial NCT07034196 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis (RA).

What interventions are being tested in trial NCT07034196?

The interventions under investigation include: Primary Care Treatment in lieu of Rheumatologist (OTHER).

Who is sponsoring clinical trial NCT07034196?

This trial is sponsored by St. Lawrence Health System, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07034196 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis (RA)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07034196's enrollment target sits among peer trials

100 9th of 17 higher than 9 of 17 other Rheumatoid Arthritis (RA) trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rheumatoid Arthritis (RA) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07034196, the US trial registry maintained by the National Library of Medicine. NCT07034196 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.